On December 17, 2020, Horizon Therapeutics reported a nationwide shortage of its biologic therapy TEPEZZA, indicated for the treatment of thyroid eye disease (TED). The company expects supply limitations to affect all healthcare providers who administer TEPEZZA, including IVX Health.
IVX is monitoring the situation closely and will continue to accommodate existing patients to the best of our ability. As product availability cannot be guaranteed at this time, IVX Health is currently not accepting new TEPEZZA patients. Providers may still refer patients to IVX Health. IVX Health can hold the referral temporarily and move forward when better visibility of future supply is achieved.
To inquire about a previously scheduled TEPEZZA appointment, please contact your IVX Health local center.
Horizon Therapeutics anticipates its TEPEZZA shortage to resolve within the first quarter of 2021. For newly prescribed TEPEZZA patients seeking treatment at IVX Health and with start date flexibility, please contact IVX Health using our Contact Us form.